13. Heart Failure and Cardiomyopathies: Clinical 1415-72

1415-72 - CANAGLIFLOZIN (CANA) REDUCES CARDIOVASCULAR (CV) AND RENAL EVENTS INDEPENDENT OF BASELINE HEART FAILURE (HF): A CREDENCE SECONDARY ANALYSIS

Session
1415 - Heart Failure and Cardiomyopathies: Clinical 7
Speakers
Pathway
13. Heart Failure and Cardiomyopathies: Clinical
Presentation Number
1415-72
Presentation Rating
 |